[HTML][HTML] Targeted protein degradation: clinical advances in the field of oncology

AKAA Salama, MV Trkulja, E Casanova… - International Journal of …, 2022 - mdpi.com
… The field of targeted protein degradation (TPD) is a rapidly developing … targeted protein
degradation approaches and focus on the current status of clinical translation of TPD in cancer

[HTML][HTML] Targeted protein degradation: mechanisms, strategies and application

L Zhao, J Zhao, K Zhong, A Tong, D Jia - … transduction and targeted …, 2022 - nature.com
… hope to provide a prime for both biologists and chemists who are interested in this vibrant
field. … Treatment of complicated diseases, such as cancer, often require more than one targets. …

Preclinical and Clinical Advances of Targeted Protein Degradation as a Novel Cancer Therapeutic Strategy: An Oncologist Perspective

X Yang, H Yin, RD Kim, JB Fleming, H Xie - Targeted Oncology, 2021 - Springer
… Since the first PROTAC was reported in 2001 [5], the field of targeted protein degradation
by small molecules has undergone rapid development, with a main focus on the advances of …

Targeted protein degradation: an emerging therapeutic strategy in cancer

SH Barghout - … Current Medicinal Chemistry-Anti-Cancer …, 2021 - ingentaconnect.com
… molecules without affecting their protein levels. An emerging … of Targeted Protein Degradation
(TPD) of cellular targets by … the field with a focus on clinical translation in cancer therapy. …

[HTML][HTML] Targeted protein degradation: A promise for undruggable proteins

KTG Samarasinghe, CM Crews - Cell chemical biology, 2021 - cell.com
field, the breadth of the proteins targeted by PROTACs and the biological effects of their
degradation… For instance, HER2 overexpression is found in breast and gastro-esophageal cancer

Targeted protein degradation by PROTACs

TK Neklesa, JD Winkler, CM Crews - Pharmacology & therapeutics, 2017 - Elsevier
… increase in the surface area that can be utilized to recruit the protein of interest to an E3 …
PIK3CA gene product PI3Kα is one of the most sought after mutated targets in various oncology

Critical assessment of targeted protein degradation as a research tool and pharmacological modality

M Kostic, LH Jones - Trends in pharmacological sciences, 2020 - cell.com
target that undergoes proteasomal degradation (Figure 1). Here, we will offer a brief introduction
to targeted protein degradation and … review of the area, please check a recent review [ …

Targeted protein degradation: expanding the toolbox

M Schapira, MF Calabrese, AN Bullock… - Nature reviews Drug …, 2019 - nature.com
… have been explored in targeted protein degradation to date. … for the field of targeted protein
degradation and review the major … degradation of target proteins and is essential in all cancer

[HTML][HTML] PROTAC'ing oncoproteins: targeted protein degradation for cancer therapy

JM Kelm, DS Pandey, E Malin, H Kansou, S Arora… - Molecular Cancer, 2023 - Springer
Target-independent resistance mechanisms including compensation by other pathways is
an additional challenge for the field of molecular cancer … MOA, targeted protein degradation (…

[HTML][HTML] PROTAC: an effective targeted protein degradation strategy for cancer therapy

SM Qi, J Dong, ZY Xu, XD Cheng, WD Zhang… - Frontiers in …, 2021 - frontiersin.org
degradation results. In this paper, we classify PROTACs according to E3 ligase and summarize
the PROTAC degradation strategies for different target proteins (… knowledge in this area. …